Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giacomini

Showing results (331-340 of 378) with videos related to

Pageof 38
Sort By:
PLOS Digital Health|September 4, 2025
Development and evaluation of a lightweight large language model chatbot for medication enquiryKabilan Elangovan, Jasmine Chiat Ling Ong, Liyuan Jin, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomicsSook Wah Yee, Christian Macdonald, Darko Mitrovic, et al.
Pharmacogenetics and Genomics|August 19, 2007
Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4)Thomas J Urban, Chen Yang, Leah L Lagpacan, et al.
Plos Biology|January 18, 2019
Organic cation transporter 3 (Oct3) is a distinct catecholamines clearance route in adipocytes mediating the beiging of white adipose tissueWenxin Song, Qi Luo, Yuping Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 2008
Identification and characterization of proximal promoter polymorphisms in the human concentrative nucleoside transporter 2 (SLC28A2)Sook Wah Yee, James E Shima, Stephanie Hesselson, et al.
American Journal of Human Genetics|April 2, 2021
Opportunities and challenges for the computational interpretation of rare variation in clinically important genesGregory McInnes, Andrew G Sharo, Megan L Koleske, et al.
Clinical Pharmacology and Therapeutics|August 10, 2018
Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical ImportanceMaciej J Zamek-Gliszczynski, Mitchell E Taub, Paresh P Chothe, et al.
Clinical Pharmacology and Therapeutics|April 2, 2025
Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2)Andrew M Riselli, Sook Wah Yee, Jia Yang, et al.
Plos Genetics|October 3, 2014
Genome-wide discovery of drug-dependent human liver regulatory elementsRobin P Smith, Walter L Eckalbar, Kari M Morrissey, et al.
Plos Genetics|December 1, 2016
Genomic Characterization of Metformin Hepatic ResponseMarcelo R Luizon, Walter L Eckalbar, Yao Wang, et al.
Pageof 38

Showing results (331-340 of 378) with videos related to

Sort By:
Pageof 38
PLOS Digital Health|September 4, 2025
Development and evaluation of a lightweight large language model chatbot for medication enquiryKabilan Elangovan, Jasmine Chiat Ling Ong, Liyuan Jin, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2023
The full spectrum of OCT1 (SLC22A1) mutations bridges transporter biophysics to drug pharmacogenomicsSook Wah Yee, Christian Macdonald, Darko Mitrovic, et al.
Pharmacogenetics and Genomics|August 19, 2007
Functional effects of protein sequence polymorphisms in the organic cation/ergothioneine transporter OCTN1 (SLC22A4)Thomas J Urban, Chen Yang, Leah L Lagpacan, et al.
Plos Biology|January 18, 2019
Organic cation transporter 3 (Oct3) is a distinct catecholamines clearance route in adipocytes mediating the beiging of white adipose tissueWenxin Song, Qi Luo, Yuping Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 23, 2008
Identification and characterization of proximal promoter polymorphisms in the human concentrative nucleoside transporter 2 (SLC28A2)Sook Wah Yee, James E Shima, Stephanie Hesselson, et al.
American Journal of Human Genetics|April 2, 2021
Opportunities and challenges for the computational interpretation of rare variation in clinically important genesGregory McInnes, Andrew G Sharo, Megan L Koleske, et al.
Clinical Pharmacology and Therapeutics|August 10, 2018
Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical ImportanceMaciej J Zamek-Gliszczynski, Mitchell E Taub, Paresh P Chothe, et al.
Clinical Pharmacology and Therapeutics|April 2, 2025
Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2)Andrew M Riselli, Sook Wah Yee, Jia Yang, et al.
Plos Genetics|October 3, 2014
Genome-wide discovery of drug-dependent human liver regulatory elementsRobin P Smith, Walter L Eckalbar, Kari M Morrissey, et al.
Plos Genetics|December 1, 2016
Genomic Characterization of Metformin Hepatic ResponseMarcelo R Luizon, Walter L Eckalbar, Yao Wang, et al.
Pageof 38